Clinical Trial Update: A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating niraparib in patients with soft tissue sarcoma who harbor tumor DNA alterations; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma
• Uterine Sarcoma

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma,Soft Tissue, Sarcoma Uterus | Phase 2 | Status: ACTIVE_NOT_RECRUITING